United States - English - NLM (National Library of Medicine)

ultimark products llc - hydroquinone (unii: xv74c1n1ae) (hydroquinone - unii:xv74c1n1ae) - hydroquinone 0.02 g in 1 g - skin lightener for the gradual fading of dark spots in the skin such as liver and age spots caused by sun exposure, age, acne, pregnancy and the use of oral contraceptives.  on children under 12 years of age unless directed by a doctor. if skin irritation becomes severe.

United States - English - NLM (National Library of Medicine)

ultimark products llc - hydroquinone (unii: xv74c1n1ae) (hydroquinone - unii:xv74c1n1ae), octinoxate (unii: 4y5p7mud51) (octinoxate - unii:4y5p7mud51) - hydroquinone 0.02 g in 1 g - skin lightener sunscreen - lightens dark spots, blemishes, freckles and discolorations of the skin caused by sun exposure, age, acne, pregnancy and the use of oral contraceptives. - contains a sunscreen to keep darkening from reoccurring. children under 12 years of age unless directed by a doctor.

United States - English - NLM (National Library of Medicine)

ultimark products llc - salicylic acid (unii: o414pz4lpz) (salicylic acid - unii:o414pz4lpz) - controls the symptoms of dandruff, seborrheic dermatitis and psoriasis - reduces and helps eliminate scalp itching, flaking and scaling associated with dandruff, seborrheic dermatitis and psoriasis - helps prevent recurrence of the symptoms of dandruff, seborrheic dermatitis and psoriasis

United States - English - NLM (National Library of Medicine)

ultimark products llc - coal tar (unii: r533eso2ec) (coal tar - unii:r533eso2ec), menthol (unii: l7t10eip3a) (menthol - unii:l7t10eip3a) - controls the symptoms of dandruff, seborrheic dermatitis and psoriasis controls scalp itch - relieves and helps stop the recurrence of scalp itching, irritation, redness, flaking and scaling associated with dandruff, seborrheic dermatitis and psoriasis - extra relief of itching due to dandruff

Singapore - English - HSA (Health Sciences Authority)

roche diagnostics asia pacific pte ltd - clinical chemistry - immunoassay for the in vitro quantitative determination of adrenocorticotropic hormone (acth) in human edta plasma. the electrochemiluminescence immunoassay “eclia” is intended for use on cobas e immunoassay analyzers.

Singapore - English - HSA (Health Sciences Authority)

roche diagnostics asia pacific pte ltd - immunology - immunoassay for the in vitro quantitative determination of placental growth factor (plgf) in human serum. the plgf assay is used in combination with the elecsys sflt‑1 assay to determine the sflt‑1/plgf ratio. the sflt‑1/plgf ratio is intended for use as an aid in the diagnosis of preeclampsia in conjunction with other diagnostic and clinical information. in addition the sflt‑1/plgf ratio is intended for use as an aid in short-term prediction of preeclampsia (rule-out and rule-in) in pregnant women with suspicion of preeclampsia in conjunction with other diagnostic and clinical information. this assay is intended for the use as one component, in combination with other parameters, to evaluate the risk of early-onset preeclampsia during the first trimester of pregnancy. the electrochemiluminescence immunoassay “eclia” is intended for use on cobas e immunoassay analyzers.

Singapore - English - HSA (Health Sciences Authority)

roche diagnostics asia pacific pte ltd - immunology - immunoassay for the in vitro quantitative determination of soluble fms‑like tyrosine kinase‑1 (sflt‑1) in human serum. the elecsys sflt‑1 assay is used in combination with the elecsys plgf assay to determine the sflt‑1/plgf ratio. the sflt‑1/plgf ratio is intended for use as an aid in the diagnosis of preeclampsia in conjunction with other diagnostic and clinical information. in addition the sflt‑1/plgf ratio is intended for use as an aid in short-term prediction of preeclampsia (rule-out and rule-in) in pregnant women with suspicion of preeclampsia in conjunction with other diagnostic and clinical information. the electrochemiluminescence immunoassay “eclia” is intended for use on cobas e immunoassay analyzers.

Singapore - English - HSA (Health Sciences Authority)

roche diagnostics asia pacific pte ltd - immunology - roche diagnostics elecsys® c-peptide is an immunoassay for the in vitro quantitative determination of c-peptide in human serum, plasma and urine. the assay is intended for use as an aid in the diagnosis and treatment of patients with abnormal insulin secretion. the electrochemiluminescence immunoassay “eclia” is intended for use on elecsys and cobas e immunoassay analyzers.

Singapore - English - HSA (Health Sciences Authority)

roche diagnostics asia pacific pte ltd - immunology - roche diagnostics elecsys hgh is an immunoassay for the in vitro quantitative determination of human growth hormone (hgh; forms with molecular masses of 20 kda and 22 kda) in human serum and plasma. the electrochemiluminescence immunoassay “eclia” is intended for use on elecsys, and cobas e immunoassay analyzers.

Singapore - English - HSA (Health Sciences Authority)

roche diagnostics asia pacific pte ltd - immunology - roche diagnostics elecsys® insulin is an immunoassay for the in vitro quantitative determination of human insulin in human serum and plasma. the determination of insulin is utilized in the diagnosis and therapy of various disorders of carbohydrate metabolism, including diabetes mellitus and hypoglycemia. the electrochemiluminescence immunoassay “eclia” is intended for use on elecsys and cobas e immunoassay analyzers.